Duration and dosing of systemic corticosteroids for acute exacerbation of COPD, protocol for a systematic review with meta-analysis of randomized trials and cohort studies
<h4>Purpose</h4> Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a leading cause of deterioration in patients with otherwise stably controlled COPD. Treatments of AECOPD often require the use of corticosteroid therapy in conjunction with bronchodilators and antibi...
Main Authors: | Raymond Yin, Yiyang Wang, Yue Ying, Mutian Ding, Yunqing Ouyang, Emily Yuan, Daniel Ye, Shirley Yuan, Guanying Li, Winston Hou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470871/?tool=EBI |
Similar Items
-
Nebulized corticosteroids in the management of acute exacerbation of COPD
by: Gaude G, et al.
Published: (2010-01-01) -
Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studies
by: Zhen Zhao, et al.
Published: (2023-01-01) -
COPD exacerbation: factors influencing hospitalization duration.
by: K. Yu. Gashynova
Published: (2015-03-01) -
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
by: Siddiqui, S, et al.
Published: (2018) -
Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
by: Gong Y, et al.
Published: (2022-09-01)